NL

Nikhil Lalwani

North America, New York, United States, New York

Description

Nikhil Lalwani President & CEO at ANI Pharmaceuticals. He attended The Wharton School.

Investor Profile

Nikhil Lalwani has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Pre Seed rounds (top funding stages).
  • Majority of deals are located in Singapore.
  • Strong thematic focus on Recruiting, Software Engineering, Staffing Agency.

Stage Focus

  • Pre Seed (100%)

Country Focus

  • Singapore (100%)

Industry Focus

  • Recruiting
  • Software Engineering
  • Staffing Agency
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Nikhil Lalwani frequently co-invest with?

Son Tech Investment
Asia, NA - Vietnam, Vietnam, Ho Chi Minh City
Co-Investments: 1
ZEMU Venture Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
January Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Goodwater Capital
North America, California, United States, Burlingame
Co-Investments: 1

Which angels does Nikhil Lalwani often collaborate with?

Pritesh Gupta
Asia, Karnataka, India, Bangalore
Shared Deals: 1
Mohammed Alabsi
Asia, Jakarta Raya, Indonesia, Jakarta
Shared Deals: 1

What are some of recent deals done by Nikhil Lalwani?

Startup oi

Singapore, Central Region, Singapore

Startup oi is a professional and social platform for engineers.

RecruitingSoftware EngineeringStaffing Agency
Pre SeedJan 6, 2022
Amount Raised: $1,000,000